Format
Sort by

Send to

Choose Destination

Links from Books

Items: 3

1.

Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging.

Hasegawa Y, Oyama N, Nagase K, Fujibayashi Y, Furukawa T, Murayama Y, Arai Y, Saito S, Welch MJ, Yokoyama O.

Nucl Med Biol. 2012 Oct;39(7):944-7. doi: 10.1016/j.nucmedbio.2012.05.008. Epub 2012 Jul 4.

PMID:
22766258
2.

Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer.

Saito S, Murayama Y, Pan Y, Taima T, Fujimura T, Murayama K, Sadilek M, Egawa S, Ueno S, Ito A, Ishidoya S, Nakagawa H, Kato M, Satoh M, Endoh M, Arai Y.

Int J Cancer. 2008 Aug 1;123(3):633-40. doi: 10.1002/ijc.23490.

3.

RM2 antigen (beta1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer.

Saito S, Egawa S, Endoh M, Ueno S, Ito A, Numahata K, Satoh M, Kuwao S, Baba S, Hakomori S, Arai Y.

Int J Cancer. 2005 May 20;115(1):105-13.

Supplemental Content

Support Center